Skip to content
CPhA Logo

Webinar Evaluation: Beyond the numbers: A pharmacist's guide to dyslipidemia management and clinical decision-making

Please rate your overall satisfaction with this webinar.(Required.)
The program met the stated learning objectives:(Required.)
Strongly disagree
Disagree
Neutral
Agree
Strongly agree
Apply current Canadian Cardiovascular Society (CCS) screening recommendations to identify patients in your daily practice requiring dyslipidemia assessment .
Evaluate patients' cardiovascular risk using the Framingham Risk Score and develop evidence-based treatment plans incorporating both lifestyle modifications and pharmacological interventions.
Implement an approach to manage statin intolerance and determine appropriate criteria for initiating add-on therapies in patients not reaching targets on maximally tolerated statin therapy
Design holistic cardiovascular risk reduction strategies that integrate dyslipidemia management with other modifiable risk factors.
Please rate the relevance of this webinar to your own pharmacy practice (if applicable):
Did you learn something new?(Required.)
Will the knowledge you gained from this learning activity be used to improve the care you provide to at least one patient (if applicable)?(Required.)
Please rate your overall satisfaction with the presenter Mike Boivin:
(Required.)
Was there any bias (e.g., corporate influence, etc...) apparent in the learning session?(Required.)
Please rate your overall satisfaction with the webinar format (presentation and polls followed by Q&A):(Required.)
What did you like best?
What could we do better?
Please select the option that best describes your position/profession:(Required.)
Please select the option that best describes your pharmacy practice/employment:(Required.)
Please select your primary practice location:(Required.)
Do you have any suggestions for future webinar topics? Please be as specific as possible:
Current Progress,
0 of 14 answered